# Pioglitazone Hydrochloride and Metformin Hydrochloride

NDC: 57237-217
Generic name: Pioglitazone Hydrochloride and Metformin Hydrochloride
Labeler / Manufacturer: Rising Pharma Holdings, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20130213

FDA application: ANDA200823

## Active ingredients

- METFORMIN HYDROCHLORIDE: 500 mg/1
- PIOGLITAZONE HYDROCHLORIDE: 15 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"57237-217"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=57237-217
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8d252dab-e868-42d3-95ea-69423d909e84